Palbace 125mg Tablet

Salt Composition: Palbociclib  
Manufacturer: PFIZER LTD  
0 0 12
MRP
:
22,500
Price
:
19,500
You Save
:
3,000 (13%)
In Stock
H1J1O1IG2C3
   Check delivery options  
 
Share: 

About

Palbace 125mg Tablet is a targeted cancer therapy that contains the active ingredient palbociclib. It belongs to a class of anticancer medications called cyclin-dependent kinase inhibitors. It is used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (cancer that has spread to other parts of the body). This medication is typically administered in combination with other anticancer drugs.

Common side effects of Palbace 125mg Tablet may include nausea, vomiting, diarrhea, fatigue, hair loss, dry skin, rash, infections, nosebleeds, decreased appetite, low blood cell counts, swelling of the lips and mouth, altered taste, dry eyes, blurred vision, and excessive tearing. Inform your doctor if any of these side effects are persistent or bothersome.

Before starting treatment, let your healthcare provider know if you are allergic to Palbace 125mg Tablet or any of its ingredients. It is important to inform your doctor if you have any symptoms of infection (such as fever, chills, or sore throat), or if you have liver or kidney problems, or a known intolerance to certain sugars. Seek medical advice immediately if you experience symptoms like a dry cough, chest pain, or difficulty breathing, as these may be signs of lung inflammation.

Also, make sure to inform your doctor about all medications you are currently taking, including prescription drugs, over-the-counter medicines, supplements, and herbal products. Women of childbearing potential should use effective contraception during treatment and for at least three weeks after the final dose. This medication is not recommended for use in children and adolescents under 18 years of age.

 Uses 

  • Breast cancer

Directions for use

This medicine should be administered by a doctor or nurse. Please do not attempt to self-administer it.


Side effects 
    

  • Decreased of appetite
  • Nausea, vomiting
  • Diarrhea
  • Swelling of lips and mouth
  • Changes in taste
  • Nose bleed
  • Dry eye, blurred vision, increased tearing
  • Tiredness
  • Hair loss
  • Dry skin, rash
  • Infections
  • Low blood cell counts
  • Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
  • Lung inflammation (chest pain, dry cough, or difficulty breathing)

    
Safety Measures

Alcohol - It is not known whether consuming alcohol is safe while taking Palbace 125mg. Consult your doctor for personalized advice.
Pregnancy - Palbace 125mg Tablet is not recommended during pregnancy, as it may harm the unborn baby. Women of childbearing potential should use effective contraception throughout the treatment and for at least three weeks after the final dose.
Breastfeeding - Palbace 125mg Tablet is not recommended while breastfeeding, as it is unknown whether the medicine passes into breast milk.
Liver - Inform your doctor if you have any liver conditions before taking Palbace 125mg, as the medication should be used with caution in patients with liver disorders.
Kidney - The effects of Palbace 125mg on the kidneys are not well established. Consult your doctor if you have any kidney-related concerns before starting treatment.

  Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient reilationshp.

Shipping Cost
Shop Location Assam, India

No comments found for this product. Be the first to comment!